Regeneron Pharmaceuticals (REGN) stock Forecast for 2021 – 2025

Regeneron Pharmaceuticals (REGN) stock Forecast for 2022 – 2026

Last update: 05-20-2022, 5:51

Sector: Healthcare

The share price of Regeneron Pharmaceuticals, Inc. (REGN) now

What analysts predict:: $702.05

52-week high/low: $747.42 / $492.13

50/200 Day Moving Average: $674.91 / $635.44

This figure corresponds to the average price over the previous 50/200 days. For Regeneron Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Regeneron Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Regeneron Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Regeneron Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one Regeneron Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in Regeneron Pharmaceuticals stock? When should I record a loss on Regeneron Pharmaceuticals stock? What are analysts' forecasts for Regeneron Pharmaceuticals stock? What is the future of Regeneron Pharmaceuticals stock?

We forecast Regeneron Pharmaceuticals stock performance using neural networks based on historical data on Regeneron Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Regeneron Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Regeneron Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Regeneron Pharmaceuticals stock

The chart below shows the historical price of Regeneron Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Regeneron Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Regeneron Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 22 646.66 632.59 657.01 3.86
May 23 654.94 649.70 660.18 1.61
May 24 653.89 640.92 669.79 4.51
May 25 635.27 624.49 646.45 3.52
May 26 638.72 627.28 646.69 3.10
May 27 657.32 644.49 672.26 4.31
May 28 661.53 644.59 668.94 3.78
May 29 656.03 650.15 661.69 1.78
May 30 663.37 648.51 668.04 3.01
May 31 665.07 648.90 678.48 4.56
Jun 01 649.32 634.99 656.39 3.37
Jun 02 667.40 650.96 682.99 4.92
Jun 03 687.48 678.02 700.45 3.31
Jun 04 684.18 678.70 695.56 2.48
Jun 05 702.78 693.11 710.43 2.50
Jun 06 710.43 692.70 725.21 4.69
Jun 07 724.98 713.38 742.84 4.13
Jun 08 731.48 724.92 745.05 2.78
Jun 09 730.07 714.42 746.19 4.45
Jun 10 725.40 714.26 740.72 3.70
Jun 11 717.51 710.16 730.37 2.85
Jun 12 713.60 701.73 721.60 2.83
Jun 13 729.59 712.78 748.27 4.98
Jun 14 727.02 721.90 737.96 2.22
Jun 15 739.82 727.51 746.68 2.64
Jun 16 741.00 727.25 755.46 3.88
Jun 17 749.30 743.07 763.21 2.71
Jun 18 744.02 729.50 760.93 4.31
Jun 19 722.36 708.49 735.53 3.82
Jun 20 722.59 717.96 739.24 2.96

Regeneron Pharmaceuticals Daily Price Targets


Regeneron Pharmaceuticals Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $646.66. Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.717%.

Pessimistic target level: 632.59

Optimistic target level: 657.01


Regeneron Pharmaceuticals Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $654.94. Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 1.587%.

Pessimistic target level: 649.70

Optimistic target level: 660.18


Regeneron Pharmaceuticals Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $653.89. Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 4.311%.

Pessimistic target level: 640.92

Optimistic target level: 669.79


Regeneron Pharmaceuticals Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $635.27. Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.396%.

Pessimistic target level: 624.49

Optimistic target level: 646.45


Regeneron Pharmaceuticals Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $638.72. Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.003%.

Pessimistic target level: 627.28

Optimistic target level: 646.69


Regeneron Pharmaceuticals Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $657.32. Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 4.130%.

Pessimistic target level: 644.49

Optimistic target level: 672.26


REGN (REGN) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 618.80 605.43 663.35 8.73
Jul. 662.79 624.62 681.28 8.32
Aug. 684.27 638.69 700.89 8.87
Sep. 681.80 646.83 695.30 6.97
Oct. 656.64 640.69 686.19 6.63
Nov. 654.28 642.50 688.43 6.67
Dec. 667.24 631.81 706.87 10.62

Regeneron Pharmaceuticals forecast for this year


Regeneron Pharmaceuticals Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $618.795. Pessimistic: $605.43. Optimistic: $663.35


Regeneron Pharmaceuticals Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $662.792. Pessimistic: $624.62. Optimistic: $681.28


Regeneron Pharmaceuticals Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $684.266. Pessimistic: $638.69. Optimistic: $700.89


Regeneron Pharmaceuticals Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $681.803. Pessimistic: $646.83. Optimistic: $695.30


Regeneron Pharmaceuticals Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $656.644. Pessimistic: $640.69. Optimistic: $686.19


Regeneron Pharmaceuticals Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $654.28. Pessimistic: $642.50. Optimistic: $688.43


Regeneron Pharmaceuticals Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $667.235. Pessimistic: $631.81. Optimistic: $706.87




Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 670.24 646.11 709.45 8.93
Feb 667.83 640.18 715.91 10.58
Mar 617.34 594.00 629.56 5.65
Apr 599.00 575.82 615.18 6.40
May 564.50 533.00 584.31 8.78
Jun 546.21 526.06 565.38 6.96
Jul 526.55 513.75 563.51 8.83
Aug 569.20 536.92 587.13 8.55
Sep 580.47 564.79 596.14 5.26
Oct 585.69 545.10 620.48 12.15
Nov 621.54 608.11 643.35 5.48
Dec 656.22 643.82 697.56 7.70

Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 676.89 648.26 692.12 6.34
Feb 653.74 623.73 667.86 6.61
Mar 649.62 616.29 664.24 7.22
Apr 673.01 646.96 706.93 8.48
May 685.73 665.36 704.86 5.60
Jun 725.22 701.07 775.48 9.60
Jul 761.78 714.47 815.25 12.36
Aug 739.84 715.20 764.47 6.45
Sep 693.23 659.54 737.52 10.57
Oct 657.66 611.50 684.30 10.64
Nov 686.08 645.94 716.95 9.90
Dec 631.74 612.41 673.24 9.04



Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 604.45 587.58 634.91 7.45
Feb 642.53 628.65 677.22 7.17
Mar 632.12 603.10 650.89 7.34
Apr 628.14 611.74 660.92 7.44
May 604.39 575.56 645.19 10.79
Jun 590.79 556.76 603.02 7.67
Jul 597.17 584.28 637.48 8.35
Aug 600.94 572.81 627.98 8.78
Sep 590.66 575.24 607.67 5.34
Oct 583.22 543.85 606.31 10.30
Nov 605.26 574.76 640.13 10.21
Dec 613.43 595.22 637.17 6.59

Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 653.74 622.55 697.86 10.79
Feb 706.69 675.53 727.04 7.09
Mar 746.12 696.43 795.82 12.49
Apr 754.18 737.89 775.90 4.90
May 724.32 678.68 747.78 9.24
Jun 691.72 678.03 718.49 5.63
Jul 677.40 656.67 691.43 5.03
Aug 692.03 665.88 724.42 8.08
Sep 721.93 694.64 758.97 8.48
Oct 731.68 700.73 759.99 7.80
Nov 669.12 648.04 708.86 8.58
Dec 610.70 570.58 642.03 11.13

Regeneron Pharmaceuticals information and performance

Regeneron Pharmaceuticals, Inc. is an American biotech company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Initially, it focused on neurotrophic factors and their regenerative capabilities (hence the name), and then branched out into the study of both cytokine and tyrosine kinase receptors.

Regeneron Pharmaceuticals Address

777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, US

Market Capitalization: 70 907 789 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 9 233 000 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 8.97

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 5.69

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 71.97

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.923

Quarterly Revenue Growth YOY: 1.044

Trailing PE: 8.97

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 15.08

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.955

Enterprise Value (EV) /Revenue

EV To EBITDA: 6.88

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 108028000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.